Teachers Advisors’s Larimar Therapeutics LRMR Stock Holding History

Teachers Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$172K	Hold	5,220	–	–	﹤0.01%	2868
2018 Q4	$310K	Buy	5,220 +680	+15%	+$67.1K	﹤0.01%	2704
2018 Q3	$637K	Buy	4,540 +2,075	+84%	+$252K	﹤0.01%	2531
2018 Q2	$303K	Buy	+2,465	New	+$209K	﹤0.01%	2865
2017 Q2	–	Sell	-2,673	Closed	-$149K	–	3151
2017 Q1	$149K	Hold	2,673	–	–	﹤0.01%	2928
2016 Q4	$102K	Hold	2,673	–	–	﹤0.01%	3006
2016 Q3	$106K	Hold	2,673	–	–	﹤0.01%	2997
2016 Q2	$192K	Sell	2,673 -358	-12%	-$28.3K	﹤0.01%	2910
2016 Q1	$243K	Hold	3,031	–	–	﹤0.01%	2719
2015 Q4	$229K	Buy	3,031 +791	+35%	+$127K	﹤0.01%	2821
2015 Q3	$859K	Buy	2,240 +120	+6%	+$54.1K	﹤0.01%	2084
2015 Q2	$881K	Buy	2,120 +1,361	+179%	+$569K	﹤0.01%	2197
2015 Q1	$361K	Buy	759 +223	+42%	+$106K	﹤0.01%	2622
2014 Q4	$198K	Hold	536	–	–	﹤0.01%	2901
2014 Q3	$126K	Buy	+536	New	+$121K	﹤0.01%	3014

Other funds holding LRMR

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Teachers Advisors's LRMR Position: Q1 2019 in Review

Teachers Advisors held its Larimar Therapeutics (LRMR) position steady in Q1 2019 at 5,220 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2868.

Teachers Advisors first reported a position in LRMR in Q3 2014 and has held it in 15 quarters since. The position peaked at $881K in Q2 2015. 85 funds tracked by Wall St. Rank hold LRMR as of Q1 2019.

Teachers Advisors held 5,220 shares of Larimar Therapeutics worth $172K as of Q1 2019.
Teachers Advisors left its Larimar Therapeutics share count unchanged in Q1 2019.
Larimar Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2868 holding.
Teachers Advisors first reported a position in Larimar Therapeutics in Q3 2014 and has held it in 15 quarters since.
Teachers Advisors's Larimar Therapeutics position peaked at $881K in Q2 2015.
85 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.